Neutropenia News and Research

RSS
Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils, the most important type of white blood cell, in the blood.
ASH establishes new blood reference ranges for Duffy-null individuals

ASH establishes new blood reference ranges for Duffy-null individuals

New drug effectively decreases recurrence of and death from endometrial cancer

New drug effectively decreases recurrence of and death from endometrial cancer

Sacituzumab govitecan combination misses progression-free survival endpoint in metastatic NSCLC

Sacituzumab govitecan combination misses progression-free survival endpoint in metastatic NSCLC

Optimized EAP regimen delivers outstanding mobilization effects in multiple myeloma and lymphoma patients

Optimized EAP regimen delivers outstanding mobilization effects in multiple myeloma and lymphoma patients

Niche-targeted therapies offer a fresh approach to regenerative medicine

Niche-targeted therapies offer a fresh approach to regenerative medicine

New all-oral regimen improves treatment convenience for AML patients

New all-oral regimen improves treatment convenience for AML patients

Study finds serious blood-related side effects associated with antibody-drug conjugates

Study finds serious blood-related side effects associated with antibody-drug conjugates

New T-cell engager therapy shows effectiveness in advanced solid tumors

New T-cell engager therapy shows effectiveness in advanced solid tumors

CAR-PRISM trial reports promising results in high-risk smoldering multiple myeloma

CAR-PRISM trial reports promising results in high-risk smoldering multiple myeloma

Single CAR T infusion shows strong response in smoldering multiple myeloma patients

Single CAR T infusion shows strong response in smoldering multiple myeloma patients

Antibody therapy clears residual multiple myeloma in early trial

Antibody therapy clears residual multiple myeloma in early trial

FOLFIRINOX shows promise as a second-line option for advanced biliary tract cancer

FOLFIRINOX shows promise as a second-line option for advanced biliary tract cancer

New antibody-drug conjugate iza-bren may offer promising treatment option for EGFR-mutated NSCLC patients

New antibody-drug conjugate iza-bren may offer promising treatment option for EGFR-mutated NSCLC patients

New global guidelines aim to make clozapine safer and more accessible

New global guidelines aim to make clozapine safer and more accessible

Deep B cell depletion offers new hope for rheumatologic and musculoskeletal diseases

Deep B cell depletion offers new hope for rheumatologic and musculoskeletal diseases

Early camizestrant therapy keeps advanced breast cancer in check

Early camizestrant therapy keeps advanced breast cancer in check

Refining the diagnosis of large granular lymphocytic leukemias and their mimics

Refining the diagnosis of large granular lymphocytic leukemias and their mimics

New treatment option for advanced thymic carcinoma shows promise

New treatment option for advanced thymic carcinoma shows promise

Glucarpidase shows promise in treating kidney toxicity from methotrexate

Glucarpidase shows promise in treating kidney toxicity from methotrexate

PATINA trial demonstrates benefit of palbociclib in HR+ HER2+ metastatic breast cancer

PATINA trial demonstrates benefit of palbociclib in HR+ HER2+ metastatic breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.